{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:15:34Z","timestamp":1649027734271},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Fogarty International Centre, the National Heart Lung and Blood Institute, and the Common Fund of the National Institutes of Health.","award":["R24 TW008861."],"award-info":[{"award-number":["R24 TW008861."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1761-0","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T20:36:44Z","timestamp":1450125404000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The safety and efficacy of prednisolone in preventing reaccumulation of ascites among endomyocardial fibrosis patients in Uganda: a randomized clinical trial"],"prefix":"10.1186","volume":"8","author":[{"given":"Yvonne Brenda","family":"Nabunnya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kayima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Freers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"1761_CR1","first-page":"S11","volume":"73","author":"CL Sezi","year":"1996","unstructured":"Sezi CL. Effect of protein deficient cassava diet on Cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man. East Afr Med J. 1996;73:S11\u20136.","journal-title":"East Afr Med J"},{"key":"1761_CR2","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0140-6736(05)72932-9","volume":"355","author":"J Freers","year":"2000","unstructured":"Freers J, et al. Endomyocardial fibrosis syndrome in Uganda. Lancet. 2000;355:1994\u20135.","journal-title":"Lancet."},{"issue":"3","key":"1761_CR3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/hrt.2007.136101","volume":"94","author":"AO Mocumbi","year":"2008","unstructured":"Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart. 2008;94(3):384\u201390.","journal-title":"Heart."},{"key":"1761_CR4","first-page":"28","volume":"4","author":"KH Mayanja","year":"1997","unstructured":"Mayanja KH, Freers J, Rutakingirwa M. Ascites in endomyocardial fibrosis. C Hastings Postgrad J. 1997;4:28\u201330.","journal-title":"C Hastings Postgrad J."},{"key":"1761_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(96)90383-9","volume":"347","author":"J Freers","year":"1996","unstructured":"Freers J, et al. Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet. 1996;347:197.","journal-title":"Lancet"},{"issue":"4","key":"1761_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1371\/journal.pntd.0000661","volume":"4","author":"A Mocumbi","year":"2010","unstructured":"Mocumbi A, Latif N, Yacoub MH. Presence of circulating anti-myosin antibodies in endomyocardial fibrosis. PLoS Negl Trop Dis. 2010;4(4):661.","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"1761_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P, Bernardi M, Ochs A, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258\u201366.","journal-title":"Hepatology"},{"key":"1761_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa0708629","volume":"359","author":"AO Mocumbi","year":"2008","unstructured":"Mocumbi AO, et al. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359:43\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"1761_CR9","first-page":"2","volume":"8","author":"CL Sezi","year":"1991","unstructured":"Sezi CL. New findings: EMF a disease of growing children and child bearing women. Uganda Med J. 1991;8(3):2\u20134.","journal-title":"Uganda Med J."},{"key":"1761_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/hrt.2007.136101","volume":"94","author":"AO Mocumbi","year":"2008","unstructured":"Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies:II. Endomyocardial fibrosis. Heart. 2008;94:384\u201390.","journal-title":"Heart."},{"key":"1761_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3156.1999.43376.x","volume":"4","author":"M Rutakingirwa","year":"1999","unstructured":"Rutakingirwa M, et al. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health. 1999;4:229\u201335.","journal-title":"Trop Med Int Health"},{"issue":"103","key":"1761_CR12","first-page":"45","volume":"26","author":"H Mayanja-Kizza","year":"2000","unstructured":"Mayanja-Kizza H, Gerwing E, Rutakingirwa M, et al. Tropical endomyocardial fibrosis in Uganda: the tribal and geographic distribution and the association with eosinophilia. Cardiologie Tropicale. 2000;26(103):45\u20138.","journal-title":"Cardiologie Tropicale."},{"issue":"1","key":"1761_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, et al. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1761-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T09:48:31Z","timestamp":1567417711000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1761-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"783"}}